Suven Life Sciences Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
5,103
5,209
4,995
5,387
6,126
Cost of Goods Sold (COGS) incl. D&A
2,345
3,076
3,062
3,131
3,291
Gross Income
2,759
2,132
1,933
2,256
2,835
SG&A Expense
636
630
1,071
1,187
1,155
EBIT
2,105
1,480
-
-
1,675
Unusual Expense
2
-
1
-
-
Non Operating Income/Expense
16
60
150
221
315
Interest Expense
105
47
59
57
46
Pretax Income
2,027
1,516
976
1,231
1,955
Income Tax
586
428
257
359
718
Consolidated Net Income
1,442
1,088
718
872
1,237
Net Income
1,442
1,088
718
872
1,237
Net Income After Extraordinaries
1,442
1,088
718
872
1,237
Net Income Available to Common
1,442
1,088
718
872
1,237
EPS (Basic)
12.34
9.04
5.64
6.85
9.72
Basic Shares Outstanding
117
120
127
127
127
EPS (Diluted)
12.34
9.04
5.64
6.85
9.72
Diluted Shares Outstanding
117
120
127
127
127
EBITDA
2,219
1,734
1,096
1,334
1,923
Other Operating Expense
18
22
6
12
5
Non-Operating Interest Income
15
23
25
7
9
About Suven Life Sciences
View Profile
